Compositions and methods for inhibiting gene expression of hepatitis B virus
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Aug 19, 2014
Grant Date -
Jan 3, 2013
app pub date -
Jun 28, 2012
filing date -
Jun 30, 2011
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The invention relates to a double-stranded ribonucleic acid (dsRNA) for inhibiting the expression of a Hepatitis B Virus gene. The invention also relates to a pharmaceutical composition comprising the dsRNA or nucleic acid molecules or vectors encoding the same together with a pharmaceutically acceptable carrier; methods for treating diseases caused by Hepatitis B Virus infection using said pharmaceutical composition; and methods for inhibiting the expression of a Hepatitis B Virus gene in a cell.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully